Ocular Oncology News

The FDA granted orphan drug designation to IOA-244 for the treatment of uveal melanoma, according to a press release from iOnctura.

NEW YORK — In a presentation at OSN New York Retina, Jasmine H. Francis, MD, FACS, offers insights for retina surgeons on distinguishing between malignant and benign tumors.

The FDA granted de novo classification to the SeCore CDx HLA Sequencing System for use as a companion diagnostic with Kimmtrak for metastatic or unresectable uveal melanoma, according to a Thermo Fisher Scientific press release.

A 73-year-old man presented to the emergency department at Tufts Medical Center with shortness of breath and blurry vision in the right eye for the past 2 months.

CHICAGO — AU-011 helped preserve vision in patients with early-stage choroidal melanoma, according to a study presented at the American Academy of Ophthalmology meeting.

GENEVA — Two new classification systems allow for improved stratification of patients with retinoblastoma, according to study results presented at World Cancer Congress.

CHICAGO — OCT accurately staged skin cancers, allowing for better diagnosis of basal cell carcinoma, prediction of margins and improved planning for Mohs surgery, according to a study presented here.

MONTEREY, Calif. — Progress is being made in the advancement of vision-sparing treatments for uveal melanoma, according to Alison Skalet, MD, PhD.

MONTEREY, Calif. — The aqueous humor is important for diagnosis, prognosis and objective monitoring of treatment response in cases of retinoblastoma, Jesse L. Berry, MD, told colleagues here.

MONTEREY, Calif. — Interferon alpha-2b, 5-fluorouracil and mitomycin C can all be used topically for conjunctival tumors, Lauren A. Dalvin, MD, said at the Women in Ophthalmology Summer Symposium.